Celldex Therapeutics Inc. (CLDX) Social Stream



Celldex Therapeutics Inc. (CLDX): $31.78

0.18 (+0.57%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add CLDX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#342 of 347

in industry

CELLDEX THERAPEUTICS INC (CLDX) Price Targets From Analysts

Use the tables below to see what analysts covering CELLDEX THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-14 5 $68 $60 $64.833 $31.6 105.17%
2022-03-01 6 $68 $60 $64.833 $31.6 105.17%
2022-05-06 6 $68 $59 $64.5 $31.6 104.11%
2022-08-09 5 $73 $59 $66.8 $31.6 111.39%
2022-10-10 5 $73 $55 $64.6 $31.6 104.43%
2023-02-27 6 $73 $55 $64.333 $31.6 103.59%
2023-05-05 6 $73 $55 $65 $31.6 105.7%
2023-08-09 6 $73 $54 $64.833 $31.6 105.17%
2023-08-11 6 $73 $54 $64.5 $31.6 104.11%
2023-10-19 7 $73 $21 $58.285 $31.6 84.45%
2023-11-03 7 $73 $21 $59.571 $31.6 88.52%
2023-11-04 7 $73 $21 $59.285 $31.6 87.61%
2023-11-07 7 $80 $27 $64 $31.6 102.53%
2023-11-13 7 $80 $27 $63.285 $31.6 100.27%

The Trend in the Analyst Price Target


Over the past 37 weeks, CLDX's average price target has gone down $1.72.

CLDX reports an average of 94.6% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-22 6 73 55 65.000 36.31 79.01%
2023-06-12 6 73 54 64.833 37.09 74.8%
2023-08-09 6 73 54 64.833 30.52 112.43%
2023-08-11 6 73 54 64.500 30.23 113.36%
2023-08-22 7 73 21 58.285 28.98 101.12%

CLDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 6 0 0 1 1 7

The Trend in the Broker Recommendations


Over the past 26 weeks, CLDX's average broker recommendation rating worsened by 0.57.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, CELLDEX THERAPEUTICS INC's variance in analysts' estimates is lower than -652.06% of them.
  • CLDX has a higher upside potential (average analyst target price relative to current price) than 1312.28% of all US stocks.
  • In the context of Pharmaceutical Products stocks, CELLDEX THERAPEUTICS INC's average analyst price target is greater than 1300.61% of them.
  • In the context of stocks in the mid market cap category, CELLDEX THERAPEUTICS INC's number of analysts covering the stock is greater than 567.33% of them.

Stocks similar to CELLDEX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEOG, EVO, and ZNTL.

Make investment decisions regarding CLDX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!